Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Southeast Retina Center

Verified

Basic Information

Site Overview

Source: Human-provided.

Southeast Retina Center is a specialized ophthalmology practice and full-service diagnostic and surgical center focused on diseases of the retina, vitreous, and macula. Headquartered in Augusta, Georgia, the practice provides advanced retinal care using state-of-the-art diagnostic imaging, laser treatments, intravitreal injections, vitreoretinal surgery, and clinical research programs. The center treats a wide range of retinal conditions, including macular degeneration, diabetic retinopathy, retinal detachments, and other vision-threatening disorders. With multiple locations across Georgia and South Carolina, including its main facility at Southeast Retina Center, the organization is committed to delivering specialized, technology-driven eye care while working closely with referring ophthalmologists and optometrists

Source: Trial-derived.
56Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
31Completed Trials
Source: Trial-derived.
43Unique Conditions
Source: Trial-derived.
38Unique Sponsors

Conditions

Source: Trial-derived. Diabetic Macular Edema (7)Source: Trial-derived. Geographic Atrophy (7)Source: Trial-derived. Macular Degeneration (7)Source: Trial-derived. Neovascular Age-related Macular Degeneration (7)Source: Trial-derived. Diabetic Retinopathy (4)Source: Trial-derived. Dry Age-related Macular Degeneration (4)Source: Trial-derived. Macular Edema (3)Source: Trial-derived. Neovascular Age-Related Macular Degeneration (3)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (13)Source: Trial-derived. Kodiak Sciences Inc (7)Source: Trial-derived. Genentech, Inc. (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Clearside Biomedical, Inc. (3)Source: Trial-derived. Gyroscope Therapeutics Limited (3)Source: Trial-derived. Novartis Pharmaceuticals (3)Source: Trial-derived. Apellis Pharmaceuticals, Inc. (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Fundus photography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravitreal injection
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Best-corrected visual acuity testing
Source: AI-inferred. Complement C5 quantification
Source: AI-inferred. Fundus autofluorescence (FAF) imaging
Source: AI-inferred. Fundus autofluorescence imaging
Source: AI-inferred. Letter-chart visual acuity testing
Source: AI-inferred. Low-luminance visual acuity testing (neutral density filter)
Source: AI-inferred. Ocular implant refill-exchange procedure
Source: AI-inferred. Quantitative contrast sensitivity function testing (qCSF)